These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 12939515)
41. n-3 Polyunsaturated fatty acids, fatal ischemic heart disease, and nonfatal myocardial infarction in older adults: the Cardiovascular Health Study. Lemaitre RN; King IB; Mozaffarian D; Kuller LH; Tracy RP; Siscovick DS Am J Clin Nutr; 2003 Feb; 77(2):319-25. PubMed ID: 12540389 [TBL] [Abstract][Full Text] [Related]
42. Dietary long-chain omega-3 fatty acids of marine origin: a comparison of their protective effects on coronary heart disease and breast cancers. Judé S; Roger S; Martel E; Besson P; Richard S; Bougnoux P; Champeroux P; Le Guennec JY Prog Biophys Mol Biol; 2006; 90(1-3):299-325. PubMed ID: 16005051 [TBL] [Abstract][Full Text] [Related]
43. Potential applications of fish oils rich in omega-3 polyunsaturated fatty acids in the management of gastrointestinal cancer. Eltweri AM; Thomas AL; Metcalfe M; Calder PC; Dennison AR; Bowrey DJ Clin Nutr; 2017 Feb; 36(1):65-78. PubMed ID: 26833289 [TBL] [Abstract][Full Text] [Related]
44. Omega-3 fatty acids and cardiovascular disease: new developments and applications. Harris WS; Dayspring TD; Moran TJ Postgrad Med; 2013 Nov; 125(6):100-13. PubMed ID: 24200766 [TBL] [Abstract][Full Text] [Related]
45. Docosahexaenoic and eicosapentaenoic acids inhibit human lymphoproliferative responses in vitro but not the expression of T cell surface activation markers. Khalfoun B; Thibault G; Lacord M; Gruel Y; Bardos P; Lebranchu Y Scand J Immunol; 1996 Mar; 43(3):248-56. PubMed ID: 8602457 [TBL] [Abstract][Full Text] [Related]
46. EPA:DHA 6:1 is a superior omega-3 PUFAs formulation attenuating platelets-induced contractile responses in porcine coronary and human internal mammary artery by targeting the serotonin pathway via an increased endothelial formation of nitric oxide. Zgheel F; Perrier S; Remila L; Houngue U; Mazzucotelli JP; Morel O; Auger C; Schini-Kerth VB Eur J Pharmacol; 2019 Jun; 853():41-48. PubMed ID: 30878386 [TBL] [Abstract][Full Text] [Related]
47. Enriched Endogenous Omega-3 Polyunsaturated Fatty Acids Protect Cortical Neurons from Experimental Ischemic Injury. Shi Z; Ren H; Luo C; Yao X; Li P; He C; Kang JX; Wan JB; Yuan TF; Su H Mol Neurobiol; 2016 Nov; 53(9):6482-6488. PubMed ID: 26611833 [TBL] [Abstract][Full Text] [Related]
48. Omega-3 fatty acids and HDL. How do they work in the prevention of cardiovascular disease? Burillo E; Martín-Fuentes P; Mateo-Gallego R; Baila-Rueda L; Cenarro A; Ros E; Civeira F Curr Vasc Pharmacol; 2012 Jul; 10(4):432-41. PubMed ID: 22339302 [TBL] [Abstract][Full Text] [Related]
49. Effects of Omegaven®, EPA, DHA and oxaliplatin on oesophageal adenocarcinoma cell lines growth, cytokine and cell signal biomarkers expression. Eltweri AM; Howells LM; Thomas AL; Dennison AR; Bowrey DJ Lipids Health Dis; 2018 Jan; 17(1):19. PubMed ID: 29378575 [TBL] [Abstract][Full Text] [Related]
50. ω3-polyunsaturated fatty acids suppress lipoprotein-associated phospholipase A2 expression in macrophages and animal models. Li Z; Ren W; Han X; Liu X; Wang G; Zhang M; Pang D; Ouyang H; Tang X Mol Nutr Food Res; 2015 Sep; 59(9):1771-9. PubMed ID: 26018800 [TBL] [Abstract][Full Text] [Related]
51. [Role of omega-3 fatty acids in cardiovascular disease prevention]. Piñeiro-Corrales G; Lago Rivero N; Culebras-Fernández JM Nutr Hosp; 2013; 28(1):1-5. PubMed ID: 23808424 [TBL] [Abstract][Full Text] [Related]
52. Effects of omega-3 polyunsaturated fatty acids on cardiac myocyte protection. Bei R; Frigiola A; Masuelli L; Marzocchella L; Tresoldi I; Modesti A; Galvano F Front Biosci (Landmark Ed); 2011 Jan; 16(5):1833-43. PubMed ID: 21196268 [TBL] [Abstract][Full Text] [Related]
53. In vivo modeling of docosahexaenoic acid and eicosapentaenoic acid-mediated inhibition of both platelet function and accumulation in arterial thrombi. Adili R; Voigt EM; Bormann JL; Foss KN; Hurley LJ; Meyer ES; Veldman AJ; Mast KA; West JL; Whiteheart SW; Holinstat M; Larson MK Platelets; 2019; 30(2):271-279. PubMed ID: 29286871 [TBL] [Abstract][Full Text] [Related]
54. Long-chain omega-3 fatty acids: time to establish a dietary reference intake. Flock MR; Harris WS; Kris-Etherton PM Nutr Rev; 2013 Oct; 71(10):692-707. PubMed ID: 24117792 [TBL] [Abstract][Full Text] [Related]
55. n-3 polyunsaturated fatty acids stimulate osteoclastogenesis through PPARγ-mediated enhancement of c-Fos expression, and suppress osteoclastogenesis through PPARγ-dependent inhibition of NFkB activation. Nakanishi A; Tsukamoto I J Nutr Biochem; 2015 Nov; 26(11):1317-27. PubMed ID: 26303404 [TBL] [Abstract][Full Text] [Related]
56. Dietary n-3 PUFA and CVD: a review of the evidence. Mori TA Proc Nutr Soc; 2014 Feb; 73(1):57-64. PubMed ID: 24119287 [TBL] [Abstract][Full Text] [Related]
57. Direct protective effects of poly-unsaturated fatty acids, DHA and EPA, against activation of cardiac late sodium current: a mechanism for ischemia selectivity. Pignier C; Revenaz C; Rauly-Lestienne I; Cussac D; Delhon A; Gardette J; Le Grand B Basic Res Cardiol; 2007 Nov; 102(6):553-64. PubMed ID: 17891522 [TBL] [Abstract][Full Text] [Related]
58. Biological mechanism of antidepressant effect of omega-3 fatty acids: how does fish oil act as a 'mind-body interface'? Su KP Neurosignals; 2009; 17(2):144-52. PubMed ID: 19190401 [TBL] [Abstract][Full Text] [Related]
59. CYP-eicosanoids--a new link between omega-3 fatty acids and cardiac disease? Westphal C; Konkel A; Schunck WH Prostaglandins Other Lipid Mediat; 2011 Nov; 96(1-4):99-108. PubMed ID: 21945326 [TBL] [Abstract][Full Text] [Related]
60. Impact of n-3 fatty acids on endothelial function: results from human interventions studies. Egert S; Stehle P Curr Opin Clin Nutr Metab Care; 2011 Mar; 14(2):121-31. PubMed ID: 21252652 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]